Foreign-Trade Zone (FTZ) 35, Notification of Proposed Production Activity; PCI Pharma Services; (Pharmaceutical Products); Croydon and Philadelphia, Pennsylvania, 94704 [2024-28024]
Download as PDF
94704
Federal Register / Vol. 89, No. 230 / Friday, November 29, 2024 / Notices
automated, electronic, mechanical, or
other technological collection
techniques or other forms of information
technology.
All comments received in response to
this notice, including names and
addresses when provided, will be a
matter of public record. Comments will
be summarized and included in the
package submitted to the Office of
Management and Budget for reapproval
of the ICR as revised.
Jacqueline Emanuel,
Associate Deputy Chief, National Forest
System.
[FR Doc. 2024–27884 Filed 11–27–24; 8:45 am]
BILLING CODE 3411–15–P
(section 301), depending on the country
of origin. The applicable section 301
decisions require subject merchandise
to be admitted to FTZs in privileged
foreign status (19 CFR 146.41).
Public comment is invited from
interested parties. Submissions shall be
addressed to the Board’s Executive
Secretary and sent to: ftz@trade.gov. The
closing period for their receipt is
January 8, 2025.
A copy of the notification will be
available for public inspection in the
‘‘Online FTZ Information System’’
section of the Board’s website.
For further information, contact
Kolade Osho at Kolade.Osho@trade.gov.
[FR Doc. 2024–28026 Filed 11–27–24; 8:45 am]
Foreign-Trade Zones Board
BILLING CODE 3510–DS–P
B–59–2024]
DEPARTMENT OF COMMERCE
khammond on DSK9W7S144PROD with NOTICES
Foreign-Trade Zone (FTZ) 35,
Notification of Proposed Production
Activity; PCI Pharma Services;
(Pharmaceutical Products); Croydon
and Philadelphia, Pennsylvania
Foreign-Trade Zones Board
[B–58–2024]
PCI Pharma Services (PCI) submitted
a notification of proposed production
activity to the FTZ Board (the Board) for
its facilities in Croydon, Pennsylvania
and Philadelphia, Pennsylvania within
Subzone 35L. The notification
conforming to the requirements of the
Board’s regulations (15 CFR 400.22) was
received on November 21, 2024.
Pursuant to 15 CFR 400.14(b), FTZ
production activity would be limited to
the specific foreign-status material(s)/
component(s) and specific finished
product(s) described in the submitted
notification (summarized below) and
subsequently authorized by the Board.
The benefits that may stem from
conducting production activity under
FTZ procedures are explained in the
background section of the Board’s
website—accessible via www.trade.gov/
ftz.
The proposed finished products
include: tulisokibart dosages packed in
assembled device in single or multidose packaging and sotatercept dosages
packed in assembled device in single or
multi-dose packaging (duty-free).
The proposed foreign-status
materials/components include: autoinjector sub assembly for sotatercept;
auto-injector sub assembly for
tulisokibart; tulisokibart in pre-filled
syringes; and sotatercept in pre-filled
syringes (duty-free). The request
indicates that certain materials/
components are subject to duties under
section 301 of the Trade Act of 1974
VerDate Sep<11>2014
21:22 Nov 27, 2024
Jkt 265001
Foreign-Trade Zone (FTZ) 35,
Notification of Proposed Production
Activity; PCI Pharma Services;
(Pharmaceutical Products); Croydon
and Philadelphia, Pennsylvania
PCI Pharma Services (PCI) submitted
a notification of proposed production
activity to the FTZ Board (the Board) for
its facilities in Croydon, Pennsylvania
and Philadelphia, Pennsylvania within
Subzone 35L. The notification
conforming to the requirements of the
Board’s regulations (15 CFR 400.22) was
received on November 21, 2024.
Pursuant to 15 CFR 400.14(b), FTZ
production activity would be limited to
the specific foreign-status material(s)/
component(s) and specific finished
product(s) described in the submitted
notification (summarized below) and
subsequently authorized by the Board.
The benefits that may stem from
conducting production activity under
FTZ procedures are explained in the
background section of the Board’s
website—accessible via www.trade.gov/
ftz.
The proposed finished product
includes: cendakimab dosages packed in
single and multi-dose packaging (dutyfree).
The proposed foreign-status material/
component includes: bulk cendakimab
in filled syringes (duty-free).
Public comment is invited from
interested parties. Submissions shall be
addressed to the Board’s Executive
Secretary and sent to: ftz@trade.gov. The
PO 00000
Frm 00004
Fmt 4703
Sfmt 4703
Dated: November 22, 2024.
Elizabeth Whiteman,
Executive Secretary.
[FR Doc. 2024–28024 Filed 11–27–24; 8:45 am]
BILLING CODE 3510–DS–P
DEPARTMENT OF COMMERCE
Bureau of Industry and Security
Dated: November 22, 2024.
Elizabeth Whiteman,
Executive Secretary.
DEPARTMENT OF COMMERCE
closing period for their receipt is
January 8, 2025.
A copy of the notification will be
available for public inspection in the
‘‘Online FTZ Information System’’
section of the Board’s website.
For further information, contact
Kolade Osho at Kolade.Osho@trade.gov.
Agency Information Collection
Activities; Submission to the Office of
Management and Budget (OMB) for
Review and Approval; Comment
Request; Chemical Weapons
Convention Provisions of the Export
Administration Regulations
The Department of Commerce will
submit the following information
collection request to the Office of
Management and Budget (OMB) for
review and clearance in accordance
with the Paperwork Reduction Act of
1995, on or after the date of publication
of this notice. We invite the general
public and other Federal agencies to
comment on proposed, and continuing
information collections, which helps us
assess the impact of our information
collection requirements and minimize
the public’s reporting burden. Public
comments were previously requested
via the Federal Register on August 28,
2024, during a 60-day comment period.
This notice allows for an additional 30
days for public comments.
Agency: Bureau of Industry and
Security, Commerce.
Title: Chemical Weapons Convention
Provisions of the Export Administration
Regulations.
OMB Control Number: 0694–0117.
Form Number(s): None.
Type of Request: Regular submission,
extension of a current information
collection.
Number of Respondents: 52.
Average Time per Response: 33
minutes.
Burden Hours: 28 hours.
Needs and Uses: The Chemical
Weapons Convention (CWC) is a
multilateral arms control treaty that
seeks to achieve an international ban on
chemical weapons (CW). The CWC
prohibits, the use, development,
production, acquisition, stockpiling,
retention, and direct or indirect transfer
of chemical weapons. This collection
E:\FR\FM\29NON1.SGM
29NON1
Agencies
[Federal Register Volume 89, Number 230 (Friday, November 29, 2024)]
[Notices]
[Page 94704]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-28024]
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board
[B-58-2024]
Foreign-Trade Zone (FTZ) 35, Notification of Proposed Production
Activity; PCI Pharma Services; (Pharmaceutical Products); Croydon and
Philadelphia, Pennsylvania
PCI Pharma Services (PCI) submitted a notification of proposed
production activity to the FTZ Board (the Board) for its facilities in
Croydon, Pennsylvania and Philadelphia, Pennsylvania within Subzone
35L. The notification conforming to the requirements of the Board's
regulations (15 CFR 400.22) was received on November 21, 2024.
Pursuant to 15 CFR 400.14(b), FTZ production activity would be
limited to the specific foreign-status material(s)/component(s) and
specific finished product(s) described in the submitted notification
(summarized below) and subsequently authorized by the Board. The
benefits that may stem from conducting production activity under FTZ
procedures are explained in the background section of the Board's
website--accessible via www.trade.gov/ftz.
The proposed finished product includes: cendakimab dosages packed
in single and multi-dose packaging (duty-free).
The proposed foreign-status material/component includes: bulk
cendakimab in filled syringes (duty-free).
Public comment is invited from interested parties. Submissions
shall be addressed to the Board's Executive Secretary and sent to:
[email protected]. The closing period for their receipt is January 8, 2025.
A copy of the notification will be available for public inspection
in the ``Online FTZ Information System'' section of the Board's
website.
For further information, contact Kolade Osho at
[email protected].
Dated: November 22, 2024.
Elizabeth Whiteman,
Executive Secretary.
[FR Doc. 2024-28024 Filed 11-27-24; 8:45 am]
BILLING CODE 3510-DS-P